#liquid biopsy
Discover 4 curated intelligence briefings related to this specific topic.
Liquid Biopsies Just Rewrote the Oncology Timeline
While traditional screenings rely on specific organ targets, a new wave of blood tests is detecting 50+ cancer types simultaneously, forcing a global rethink of when and how we screen for malignancy.
Liquid Biopsies Are Racing to Outrun the Early-Onset Cancer Spike
As cancer rates climb among adults under 50, Multi-Cancer Early Detection tests are pivoting from experimental curiosity to clinical contenders. But can a methylation signal truly replace the gold standard of invasive screening?
Why is the Biological Clock Moving Faster?
From the UK Biobank's alarming data on early-onset cancer to Roche's aggressive challenge to Illumina's sequencing monopoly, the final week of June 2026 has redefined our understanding of aging and the tools we use to fight it.
Can We Afford the Future of Medicine?
While the oncology molecular diagnostic market races toward an 8.5 billion dollar valuation, a June 2026 wave of insurance tax hikes and trillion-dollar credit card debts are making the cost of survival a luxury.